Lv41
460 积分 2023-12-22 加入
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC
2小时前
已完结
[China clinical practice guideline for stage Ⅳ primary lung cancer (2024 edition)]
3天前
已完结
Recent advances in the development of EGFR degraders: PROTACs and LYTACs
3天前
已完结
Cancer statistics, 2023
6天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
7天前
已完结
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020-2023)
7天前
已完结
Targeting EGFR degradation by autophagosome degraders
15天前
已完结
Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands
15天前
已完结
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting C797S Mutation
15天前
已完结
Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates
16天前
已关闭
皖公网安备34019202002308
